© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org.
Chapter 4: Changing Patterns in Breast Cancer Incidence Trends
Affiliations of authors: Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT (TRH); Statistical Research and Applications Branch, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD (KAC, ABM, EJF)
Correspondence to: Theodore R. Holford, PhD, Department of Epidemiology and Public Health, Yale University School of Medicine, P.O. Box 208034, 60 College St., New Haven, CT 06520-8034 (e-mail: theodore.holford{at}yale.edu).
Incidence rates for breast cancer in U.S. women have steadily increased for decades, but the reasons are not well understood. A recent upturn in these trends suggests that one component may be the effect of more aggressive screening in the population. The ageperiodcohort framework, in which the temporal components associated with year of diagnosis and generation are evaluated, can assist in interpreting the elements associated with these trends. A unique approach for exploring other ways of partitioning the contribution of the different temporal components is described and applied to breast cancer incidence data (ICDO 174.0174.9) from the Surveillance, Epidemiology and End Results (SEER) registries. Single-year intervals for age and year of diagnosis were used to fit models that provide estimates of the trends associated with the individual temporal elements. A log-linear model for age, period, and cohort was fitted using Poisson regression, and estimates of the separate time trends were calculated. The trends with period increased after 1982, when more aggressive screening began, and the trend is steeper for women older than 40 years. Cohort trends have increased steadily, although recent cohorts appear to be somewhat flat for women aged 50 years or younger, whereas the trend for those older than 50 years have continued to increase. Estimates of cohort trends in rates are also provided by extrapolating what would have occurred had there been no period trend before or after 1982, thus providing an estimate of the magnitude of the upturn that occurred after the recent emphasis on screening.
This article has been cited by other articles:
![]() |
J. S. Mandelblatt, K. A. Cronin, S. Bailey, D. A. Berry, H. J. de Koning, G. Draisma, H. Huang, S. J. Lee, M. Munsell, S. K. Plevritis, et al. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms Ann Intern Med, November 17, 2009; 151(10): 738 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Tarone Re: Recent Trends in Breast Cancer Among Younger Women in the United States J Natl Cancer Inst, May 6, 2009; 101(9): 691 - 692. [Full Text] [PDF] |
||||
![]() |
N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N.A. Tosteson, N. K. Stout, D. G. Fryback, S. Acharyya, B. A. Herman, L. G. Hannah, E. D. Pisano, and for the DMIST Investigators Cost-Effectiveness of Digital Mammography Breast Cancer Screening Ann Intern Med, January 1, 2008; 148(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Anderson, A. S. Reiner, R. K. Matsuno, and R. M. Pfeiffer Shifting Breast Cancer Trends in the United States J. Clin. Oncol., September 1, 2007; 25(25): 3923 - 3929. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Feuer Chapter 1: Modeling the Impact of Adjuvant Therapy and Screening Mammography on U.S. Breast Cancer Mortality Between 1975 and 2000: Introduction to the Problem J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 2 - 6. [Full Text] [PDF] |
||||
![]() |
D. A. Berry, L. Inoue, Y. Shen, J. Venier, D. Cohen, M. Bondy, R. Theriault, and M. F. Munsell Chapter 6: Modeling the Impact of Treatment and Screening on U.S. Breast Cancer Mortality: A Bayesian Approach J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 30 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Fryback, N. K. Stout, M. A. Rosenberg, A. Trentham-Dietz, V. Kuruchittham, and P. L. Remington Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 37 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mandelblatt, C. B. Schechter, W. Lawrence, B. Yi, and J. Cullen Chapter 8: The SPECTRUM Population Model of the Impact of Screening and Treatment on U.S. Breast Cancer Trends From 1975 to 2000: Principles and Practice of the Model Methods J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. G. L. Tan, G. J. van Oortmarssen, H. J. de Koning, R. Boer, and J. D. F. Habbema Chapter 9: The MISCAN-Fadia Continuous Tumor Growth Model for Breast Cancer J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 56 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee and M. Zelen Chapter 11: A Stochastic Model for Predicting the Mortality of Breast Cancer J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 79 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Plevritis, B. M. Sigal, P. Salzman, J. Rosenberg, and P. Glynn Chapter 12: A Stochastic Simulation Model of U.S. Breast Cancer Mortality Trends From 1975 to 2000 J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 86 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Clarke, S. K. Plevritis, R. Boer, K. A. Cronin, and E. J. Feuer Chapter 13: A Comparative Review of CISNET Breast Models Used To Analyze U.S. Breast Cancer Incidence and Mortality Trends J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 96 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. F. Habbema, S. Y. G. L. Tan, and K. A. Cronin Chapter 14: Impact of Mammography on U.S. Breast Cancer Mortality, 1975-2000: Are Intermediate Outcome Measures Informative? J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Cronin, E. J. Feuer, L. D. Clarke, and S. K. Plevritis Chapter 15: Impact of Adjuvant Therapy and Mammography on U.S. Mortality From 1975 to 2000: Comparison of Mortality Results From the CISNET Breast Cancer Base Case Analysis J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 112 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. F. Habbema, C. B. Schechter, K. A. Cronin, L. D. Clarke, and E. J. Feuer Chapter 16: Modeling Cancer Natural History, Epidemiology, and Control: Reflections on the CISNET Breast Group Experience J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 122 - 126. [Full Text] [PDF] |
||||
![]() |
K. A. Cronin, A. B. Mariotto, L. D. Clarke, and E. J. Feuer Chapter 5: Additional Common Inputs for Analyzing Impact of Adjuvant Therapy and Mammography on U.S. Mortality J Natl Cancer Inst Monographs, October 1, 2006; 2006(36): 26 - 29. [Abstract] [Full Text] [PDF] |
||||




